Indonesia has one of the fastest-growing pharmaceutic💎als and healthcare sectors in the ASEAN region, in large part due to the government’s active role in encouraging development. Still, Indonesia’s healthcare services provision is ...

In Q3 2019 China’s healthcare sector continued to expan𓆉d, stimulated by further structural reforms. The period saw increased government spending on healthcare, with expenditure on health and family planning growing by 12.1% y/y to RMB 369.3bn. ...

Malaysia has one of the most developed pharmaceuticals and healthcare sectors in the ASEAN region. The country operates a dual public-private healthcare system in which the government, under the Ministry of Health (“MoH”), both reguꦉlates ...

China’s healthcare sector kept growing over the second quarter of 2019. Th🌳e period was characterised by increased government spending on healthcare, with the amount dedicated to health and family planning rising by 5.9% y/y to RMB 534.5bn in Q💦2 ...

The first quarter𒁃 of 2019 witnessed a continuous growth of China’s healthcare sector. The country promoted the implementation of the Healthy China Initiative, as well as ongoing structural reforms in the sector. The period was characterized by ...

China’s healthcare sector c൲ontinued to grow in Q4 2018, largely stimulated by the expansion of online healthcare services. The growth was attributed to increasing demand for quality healthcare, driven by the country’s strong economic ...

China is the world’s second largest pharmaceutical market after the US and the largest producer and exporter of active pharmaceutical ingredients (APIs) globally. Since it is the world’s most populous country, with a large share of agei🌼ng ...

With 1.4bn population each as of 2017, India and China are the most numerous countries out of the six forming the focus of this report. However, the t🌟wo countries differ widely in terms of per capita GDP, with that ꦓof China being more than twice that ...

India’s is the world’s 10th-largest pharmaceutical market in US dollar terms - with sales of over USD 25bn🦋 in 2017 - and the largest generic drug manufacturer and exporter globally. Strong domestic demand and robust exports have ...

In the third quarter of 2018, China’s pharmaceutical and medicine production declined by 28.5% y/y to 573,000 tonnes,𝓀 In 2018, many pharmaceutical producers were affected by the ongoing reform for new chemical drugs classification system, and ...